Goodbody Health Limited (GDBYF)
Market Cap | 36.00 |
Revenue (ttm) | 18.35M |
Net Income (ttm) | -4.15M |
Shares Out | 36.50M |
EPS (ttm) | -0.11 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 205 |
Average Volume | 21,543 |
Open | n/a |
Previous Close | n/a |
Day's Range | n/a |
52-Week Range | 0.0000 - 0.0001 |
Beta | 62.89 |
RSI | 44.73 |
Earnings Date | n/a |
About Goodbody Health
Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom. The company also operates as a vertically integrated cannabinoid (CBD) company that operates in the United Kingdom and the European Union. It has interests in COVID and blood testing clinics, CBD extraction, wholesale bulk isolate and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs. The company was formerly known as Sativa Wellness Group Inc. and... [Read more]
Full Company ProfileFinancial Performance
In 2021, Goodbody Health's revenue was 17.06 million, an increase of 755.37% compared to the previous year's 1.99 million. Losses were -2.31 million, -50.32% less than in 2020.
Financial numbers in GBP Financial StatementsNews

Goodbody Health Progress Update: Phlebotomy Services
ST PETER PORT, GUERNSEY / ACCESSWIRE / January 31, 2023 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), is pleased to announce that it has made significant progress w...

Goodbody Health Partners with Datar to Offer Innovative Cancer Screening
ST PETER PORT, GUERNSEY / ACCESSWIRE / January 26, 2023 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), is pleased to announce that it has partnered with Datar Cancer...

Board Updates
ST PETER PORT, GUERNSEY / ACCESSWIRE / December 29, 2022 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), today announces the following Board updates. Geremy Thomas wi...

Goodbody Health Announces Cash Injection for Growth Through Divestment of Polish CBD Operations
ST PETER PORT, GUERNSEY / ACCESSWIRE / December 16, 2022 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), today announces that that it has agreed to sell the Polish CB...

Board Update
ST PETER PORT, GUERNSEY / ACCESSWIRE / December 1, 2022 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), today announces that Marc Howells has resigned from the Board ...

Goodbody Health Limited Publishes Financial Results Q3 2022
ST PETER PORT, GUERNSEY / ACCESSWIRE / November 10, 2022 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), today announces its Q3 2022 unaudited Interim Financial State...

Agreement with Allied Pharmacies Adds 17 Clinics
ST PETER PORT, GUERNSEY / ACCESSWIRE / October 19, 2022 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), today announces that it has signed an agreement with Allied Ph...

Goodbody Health Announces Distribution Agreement With Tasso
ST PETER PORT, GUERNSEY / ACCESSWIRE / October 3, 2022 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), today announces that that it has signed a contract with Tasso I...

Goodbody Health Limited (Previously: Goodbody Health Inc.) Director Transfer of Ordinary Shares
ST. PETER PORT, GUERNSEY / ACCESSWIRE / August 30, 2022 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), today announces that Geremy Thomas, the Executive Chairman and...

Goodbody Health Inc. (Renamed: Goodbody Health Limited) Provides Shareholders Update on Completion of Continuation
ST PETER PORT, GUERNSEY / ACCESSWIRE / August 23, 2022 / Goodbody Health Limited (AQSE:GDBY) (OTCQB:GDBYF) ("Goodbody" or the "Company"), is pleased to confirm the completion of the Company's continua...

Goodbody Health Inc Publishes Half Year Financial Results Q2 2022
VANCOUVER, BC / ACCESSWIRE / August 19, 2022 / Goodbody Health Inc. (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce its half year 2022 unaudited Interim Financial Statements ...

Goodbody Health Inc. Provides Annual General and Special Meeting of Shareholders Update
VANCOUVER, BC / ACCESSWIRE / August 10, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody" or the "Company"), is pleased to announce the results of the Company's Annual General and Speci...

Goodbody Health Announces Annual General and Special Meeting of Shareholders
VANCOUVER, BC / ACCESSWIRE / July 14, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), announces that further to its news release dated June 10, 2022, the Company has...

Goodbody Health launches Genetic Risk Testing for Cancer and Cardiovascular Diseases
VANCOUVER, BC / ACCESSWIRE / June 20, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that it is launching new genetic cancer tests to h...

Goodbody Health Granted Care Quality Commission Registration
VANCOUVER, BC / ACCESSWIRE / June 16, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that following its application for registration wi...

AGM, Plan to De-List from the CSE, Redomicile to Guernsey, And Appointment of Peterhouse as Corporate Adviser
Aligns With Company's Substantial U.K. Presence and Supports Its Growth Strategy Redomicile to Guernsey VANCOUVER, BC / ACCESSWIRE / June 10, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goo...

Goodbody Health Announces the Launch of Its Core Health Diagnostic Check
VANCOUVER, BC / ACCESSWIRE / May 26, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that, it has launched its core UK Health check whi...

Goodbody Health Inc. Publishes Highest Quarterly Profit to Date in Q1 2022
VANCOUVER, BC / ACCESSWIRE / May 25, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce its highest comprehensive profit of £0.10m and adj...

Goodbody Health Inc. Publishes 2021 Audited Financial Statements
VANCOUVER, BC / ACCESSWIRE / May 3, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce today a positive adjusted EBITDA of £0.48 million (...

Goodbody Health Subsidiary Granted UK Home Office Controlled Drugs Licence
VANCOUVER, BC / ACCESSWIRE / April 11, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that its subsidiary, PhytoVista Laboratories, has...

Goodbody Health Products Included on FSA Novel Foods Register
VANCOUVER, BC / ACCESSWIRE / March 31, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that, following the UK Food Standard Agencies (F...

Goodbody Health Confirms Strong 2021 Revenue Continuing into 2022
VANCOUVER, BC / ACCESSWIRE / March 10, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that, the unaudited revenue figures for the year...

Goodbody Health Announces Blood Testing Technology Roll Out
VANCOUVER, BC / ACCESSWIRE / March 8, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) (Goodbody Health" or the "Company") is pleased to announce that, following a pilot project using new technolog...

Goodbody Health Announces Normal Course Issuer Bid and Restricted Share Unit Plan
VANCOUVER, BC / ACCESSWIRE / March 4, 2022 / Goodbody Health Inc. (CSE:GDBY), (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce: (i) its intention to initiate a normal course i...